IgE levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval

Clin Exp Allergy. 2023 Nov;53(11):1222-1225. doi: 10.1111/cea.14384. Epub 2023 Sep 12.

Authors

Coco Dekkers^{1

2}, M Marlot van der Wal², Leonie van den Noort², Daphne S Bakker¹, Marjolein de Bruin-Weller¹, Femke van Wijk²

Affiliations

¹ National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
² Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

PMID: 37700483
DOI: 10.1111/cea.14384

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Dermatitis, Atopic* / drug therapy
Humans
Immunoglobulin E

Substances

dupilumab
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal
Immunoglobulin E